PrecisionLife offers analytics and resource support to COVID-19 coronavirus research community

April 21, 2020 Off By Dino Mustafić

PrecisionLife is extending its relationships with some of the largest COVID-19 collaborative research projects as it offers free use of its analytics platform and support from its data and biomedical science teams in the fight against COVID-19 coronavirus.

The precisionlife platform can analyse large scale, complex multi-omic and epidemiological data to generate disease insights that are not possible with current tools. It is routinely used to analyse very large anonymised patient datasets (>100,000 patients) and with detailed insights into complex diseases returned within hours.

Detailed view of the communities (sub-groups of patients and the SNPs driving their disease) identified by precisionlife in a population of patients with schizophrenia, which is a very highly heterogenous disease.

According to Precision life, the platform can be used to identify the complex genetic factors associated with patients’ different disease severity and outcomes, among other uses, and identify novel drugs targets, especially for more serious late-stage disease.

To be effective, the precisionlife tools can be used without training, and they require data from a minimum of several hundred COVID-19 patients, ideally including genotype/whole genome sequence with additional data including disease severity, PrecisionLife explained.